173 related articles for article (PubMed ID: 10527293)
1. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease.
Fass R; Ofman JJ; Gralnek IM; Johnson C; Camargo E; Sampliner RE; Fennerty MB
Arch Intern Med; 1999 Oct; 159(18):2161-8. PubMed ID: 10527293
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain.
Ofman JJ; Gralnek IM; Udani J; Fennerty MB; Fass R
Am J Med; 1999 Sep; 107(3):219-27. PubMed ID: 10492314
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease.
Bate CM; Riley SA; Chapman RW; Durnin AT; Taylor MD
Aliment Pharmacol Ther; 1999 Jan; 13(1):59-66. PubMed ID: 9892880
[TBL] [Abstract][Full Text] [Related]
4. The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease.
Ofman JJ; Dorn GH; Fennerty MB; Fass R
Aliment Pharmacol Ther; 2002 Feb; 16(2):261-73. PubMed ID: 11860409
[TBL] [Abstract][Full Text] [Related]
5. Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring.
Pandak WM; Arezo S; Everett S; Jesse R; DeCosta G; Crofts T; Gennings C; Siuta M; Zfass A
J Clin Gastroenterol; 2002 Oct; 35(4):307-14. PubMed ID: 12352293
[TBL] [Abstract][Full Text] [Related]
6. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain.
Fass R; Fennerty MB; Ofman JJ; Gralnek IM; Johnson C; Camargo E; Sampliner RE
Gastroenterology; 1998 Jul; 115(1):42-9. PubMed ID: 9649457
[TBL] [Abstract][Full Text] [Related]
7. Omeprazole as a diagnostic tool in gastroesophageal reflux disease.
Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Festen HP; Jansen EH; Tuynman HA; Schrijver M; Dieleman LA; Meuwissen SG
Am J Gastroenterol; 1997 Nov; 92(11):1997-2000. PubMed ID: 9362179
[TBL] [Abstract][Full Text] [Related]
8. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease.
Johnsson F; Weywadt L; Solhaug JH; Hernqvist H; Bengtsson L
Scand J Gastroenterol; 1998 Jan; 33(1):15-20. PubMed ID: 9489902
[TBL] [Abstract][Full Text] [Related]
9. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis.
Fass R; Ofman JJ; Sampliner RE; Camargo L; Wendel C; Fennerty MB
Aliment Pharmacol Ther; 2000 Apr; 14(4):389-96. PubMed ID: 10759617
[TBL] [Abstract][Full Text] [Related]
10. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
Katzka DA; Paoletti V; Leite L; Castell DO
Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
[TBL] [Abstract][Full Text] [Related]
11. High dose proton pump inhibitor response as an initial strategy for a clinical diagnosis of gastro-oesophageal reflux disease (GERD). Swedish multi-centre group in primary health care.
Brun J; Sörngård H
Fam Pract; 2000 Oct; 17(5):401-4. PubMed ID: 11021899
[TBL] [Abstract][Full Text] [Related]
12. Effect of wu chu yu tang on gastroesophageal reflux disease: Randomized, double-blind, placebo-controlled trial.
Shih YS; Tsai CH; Li TC; Yu CJ; Chou JW; Feng CL; Wang KT; Lai HC; Hsieh CL
Phytomedicine; 2019 Mar; 56():118-125. PubMed ID: 30668332
[TBL] [Abstract][Full Text] [Related]
13. Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease.
Fass R; Fennerty MB; Johnson C; Camargo L; Sampliner RE
J Clin Gastroenterol; 1999 Jan; 28(1):36-9. PubMed ID: 9916663
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of alginate test in gastroesophageal reflux disease].
Bordin DS; Masharova AA; Droxzdov VN; Firsova LD; Kozhurina TS
Eksp Klin Gastroenterol; 2010; (12):102-7. PubMed ID: 21560632
[TBL] [Abstract][Full Text] [Related]
15. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
Bautista J; Fullerton H; Briseno M; Cui H; Fass R
Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
[TBL] [Abstract][Full Text] [Related]
16. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease.
Johnsson F; Hatlebakk JG; Klintenberg AC; Román J; Toth E; Stubberöd A; Falk A; Edin R
Scand J Gastroenterol; 2003 Apr; 38(4):354-9. PubMed ID: 12739706
[TBL] [Abstract][Full Text] [Related]
17. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus".
Watson RG; Tham TC; Johnston BT; McDougall NI
Gut; 1997 May; 40(5):587-90. PubMed ID: 9203934
[TBL] [Abstract][Full Text] [Related]
18. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough.
Ours TM; Kavuru MS; Schilz RJ; Richter JE
Am J Gastroenterol; 1999 Nov; 94(11):3131-8. PubMed ID: 10566703
[TBL] [Abstract][Full Text] [Related]
19. Effect of omeprazole on symptoms of gastroesophageal reflux disease in children with cystic fibrosis. A randomized, double-blind, placebo-controlled trial.
Dziekiewicz M; Mielus M; Lisowska A; Walkowiak J; Sands D; Radzikowski A; Banaszkiewicz A
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):999-1005. PubMed ID: 33577055
[TBL] [Abstract][Full Text] [Related]
20. Optimal Omeprazole Dosing and Symptom Control: A Randomized Controlled Trial (OSCAR Trial).
Waghray A; Waghray N; Perzynski AT; Votruba M; Wolfe MM
Dig Dis Sci; 2019 Jan; 64(1):158-166. PubMed ID: 30094626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
